Trospectomycin

N/A

Report date: 2022/05/16 18:00:04
NME

Base Information

Drug NameTrospectomycin
Drug Alias Name丙大观霉素U-63366-FU 63366 F
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsRespiratory Tract InfectionsGonorrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Tract InfectionsGonorrhea

Other Information

ATC CodeN/A
Related LinksN/A